ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Teijin Drops New Aramid Development

by Marc S. Reisch
September 28, 2015 | APPEARED IN VOLUME 93, ISSUE 38

Teijin Aramid says it is halting a research program to develop and commercialize an aramid fiber variant with improved bullet resistance because of concerns over a key monomer’s toxicity. The monomer—a diaminophenylbenzimidazole—could be carcinogenic to workers exposed during fiber production, the Japanese firm says. The firm also found that the monomer could harm kidneys at low doses and could adversely affect reproduction. Teijin says it will refocus its research effort on other aramid fiber developments.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment